Fig. 2From: Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II–dependent kidney damageBlood Pressure time course in rats infused for 2 weeks with vehicle (○), Ang II (●), Ang II plus Losartan treatment (▲), Ang II plus Empagliflozin treatment (△) and Ang II plus the combination of Losartan and Empagliflozin treatments (□). Each bar represents the mean ± SE of 5 different rats for each experimental group, *p < 0.05 compared vs vehicle, + p < 0.05 compared vs Ang IIBack to article page